Supplementary Methods from Inhibition of ATR-Dependent Signaling by Protoapigenone and Its Derivative Sensitizes Cancer Cells to Interstrand Cross-link–Generating Agents <i>In Vitro</i> and <i>In Vivo</i> Article Swipe
Hui‐Chun Wang
,
Alan Yueh‐Luen Lee
,
Wen‐Cheng Chou
,
Chin‐Chung Wu
,
Chao‐Neng Tseng
,
Kevin Yen-Ting Liu
,
Wen-Lien Lin
,
Fang‐Rong Chang
,
Da‐Wei Chuang
,
Attila Hunyadi
,
Yang‐Chang Wu
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/1535-7163.22498293
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/1535-7163.22498293
PDF file, 75KB.
Related Topics
Concepts
Metadata
- Type
- preprint
- Language
- en
- Landing Page
- https://doi.org/10.1158/1535-7163.22498293
- https://aacr.figshare.com/articles/journal_contribution/Supplementary_Methods_from_Inhibition_of_ATR-Dependent_Signaling_by_Protoapigenone_and_Its_Derivative_Sensitizes_Cancer_Cells_to_Interstrand_Cross-link_Generating_Agents_i_In_Vitro_i_and_i_In_Vivo_i_/22498293/1/files/39956670.pdf
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4362609068
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4362609068Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1158/1535-7163.22498293Digital Object Identifier
- Title
-
Supplementary Methods from Inhibition of ATR-Dependent Signaling by Protoapigenone and Its Derivative Sensitizes Cancer Cells to Interstrand Cross-link–Generating Agents <i>In Vitro</i> and <i>In Vivo</i>Work title
- Type
-
preprintOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-04-03Full publication date if available
- Authors
-
Hui‐Chun Wang, Alan Yueh‐Luen Lee, Wen‐Cheng Chou, Chin‐Chung Wu, Chao‐Neng Tseng, Kevin Yen-Ting Liu, Wen-Lien Lin, Fang‐Rong Chang, Da‐Wei Chuang, Attila Hunyadi, Yang‐Chang WuList of authors in order
- Landing page
-
https://doi.org/10.1158/1535-7163.22498293Publisher landing page
- PDF URL
-
https://aacr.figshare.com/articles/journal_contribution/Supplementary_Methods_from_Inhibition_of_ATR-Dependent_Signaling_by_Protoapigenone_and_Its_Derivative_Sensitizes_Cancer_Cells_to_Interstrand_Cross-link_Generating_Agents_i_In_Vitro_i_and_i_In_Vivo_i_/22498293/1/files/39956670.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://aacr.figshare.com/articles/journal_contribution/Supplementary_Methods_from_Inhibition_of_ATR-Dependent_Signaling_by_Protoapigenone_and_Its_Derivative_Sensitizes_Cancer_Cells_to_Interstrand_Cross-link_Generating_Agents_i_In_Vitro_i_and_i_In_Vivo_i_/22498293/1/files/39956670.pdfDirect OA link when available
- Concepts
-
In vitro, Chemistry, Cancer research, Derivative (finance), Cell biology, Molecular biology, Biology, Biochemistry, Business, FinanceTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4362609068 |
|---|---|
| doi | https://doi.org/10.1158/1535-7163.22498293 |
| ids.doi | https://doi.org/10.1158/1535-7163.22498293 |
| ids.openalex | https://openalex.org/W4362609068 |
| fwci | 0.0 |
| type | preprint |
| title | Supplementary Methods from Inhibition of ATR-Dependent Signaling by Protoapigenone and Its Derivative Sensitizes Cancer Cells to Interstrand Cross-link–Generating Agents <i>In Vitro</i> and <i>In Vivo</i> |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T12763 |
| topics[0].field.id | https://openalex.org/fields/13 |
| topics[0].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[0].score | 0.9925000071525574 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/1312 |
| topics[0].subfield.display_name | Molecular Biology |
| topics[0].display_name | ATP Synthase and ATPases Research |
| topics[1].id | https://openalex.org/T13991 |
| topics[1].field.id | https://openalex.org/fields/28 |
| topics[1].field.display_name | Neuroscience |
| topics[1].score | 0.9843000173568726 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2804 |
| topics[1].subfield.display_name | Cellular and Molecular Neuroscience |
| topics[1].display_name | Nuclear Receptors and Signaling |
| topics[2].id | https://openalex.org/T13012 |
| topics[2].field.id | https://openalex.org/fields/13 |
| topics[2].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[2].score | 0.9638000130653381 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/1312 |
| topics[2].subfield.display_name | Molecular Biology |
| topics[2].display_name | Coenzyme Q10 studies and effects |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C202751555 |
| concepts[0].level | 2 |
| concepts[0].score | 0.7118442058563232 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q221681 |
| concepts[0].display_name | In vitro |
| concepts[1].id | https://openalex.org/C185592680 |
| concepts[1].level | 0 |
| concepts[1].score | 0.5436046719551086 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q2329 |
| concepts[1].display_name | Chemistry |
| concepts[2].id | https://openalex.org/C502942594 |
| concepts[2].level | 1 |
| concepts[2].score | 0.5107700824737549 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q3421914 |
| concepts[2].display_name | Cancer research |
| concepts[3].id | https://openalex.org/C111771559 |
| concepts[3].level | 2 |
| concepts[3].score | 0.4680022597312927 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q66295 |
| concepts[3].display_name | Derivative (finance) |
| concepts[4].id | https://openalex.org/C95444343 |
| concepts[4].level | 1 |
| concepts[4].score | 0.39975032210350037 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q7141 |
| concepts[4].display_name | Cell biology |
| concepts[5].id | https://openalex.org/C153911025 |
| concepts[5].level | 1 |
| concepts[5].score | 0.34449878334999084 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q7202 |
| concepts[5].display_name | Molecular biology |
| concepts[6].id | https://openalex.org/C86803240 |
| concepts[6].level | 0 |
| concepts[6].score | 0.26732298731803894 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[6].display_name | Biology |
| concepts[7].id | https://openalex.org/C55493867 |
| concepts[7].level | 1 |
| concepts[7].score | 0.2572479546070099 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q7094 |
| concepts[7].display_name | Biochemistry |
| concepts[8].id | https://openalex.org/C144133560 |
| concepts[8].level | 0 |
| concepts[8].score | 0.05650895833969116 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q4830453 |
| concepts[8].display_name | Business |
| concepts[9].id | https://openalex.org/C10138342 |
| concepts[9].level | 1 |
| concepts[9].score | 0.0 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q43015 |
| concepts[9].display_name | Finance |
| keywords[0].id | https://openalex.org/keywords/in-vitro |
| keywords[0].score | 0.7118442058563232 |
| keywords[0].display_name | In vitro |
| keywords[1].id | https://openalex.org/keywords/chemistry |
| keywords[1].score | 0.5436046719551086 |
| keywords[1].display_name | Chemistry |
| keywords[2].id | https://openalex.org/keywords/cancer-research |
| keywords[2].score | 0.5107700824737549 |
| keywords[2].display_name | Cancer research |
| keywords[3].id | https://openalex.org/keywords/derivative |
| keywords[3].score | 0.4680022597312927 |
| keywords[3].display_name | Derivative (finance) |
| keywords[4].id | https://openalex.org/keywords/cell-biology |
| keywords[4].score | 0.39975032210350037 |
| keywords[4].display_name | Cell biology |
| keywords[5].id | https://openalex.org/keywords/molecular-biology |
| keywords[5].score | 0.34449878334999084 |
| keywords[5].display_name | Molecular biology |
| keywords[6].id | https://openalex.org/keywords/biology |
| keywords[6].score | 0.26732298731803894 |
| keywords[6].display_name | Biology |
| keywords[7].id | https://openalex.org/keywords/biochemistry |
| keywords[7].score | 0.2572479546070099 |
| keywords[7].display_name | Biochemistry |
| keywords[8].id | https://openalex.org/keywords/business |
| keywords[8].score | 0.05650895833969116 |
| keywords[8].display_name | Business |
| language | en |
| locations[0].id | doi:10.1158/1535-7163.22498293 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://aacr.figshare.com/articles/journal_contribution/Supplementary_Methods_from_Inhibition_of_ATR-Dependent_Signaling_by_Protoapigenone_and_Its_Derivative_Sensitizes_Cancer_Cells_to_Interstrand_Cross-link_Generating_Agents_i_In_Vitro_i_and_i_In_Vivo_i_/22498293/1/files/39956670.pdf |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.1158/1535-7163.22498293 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5007869987 |
| authorships[0].author.orcid | https://orcid.org/0000-0003-1414-1595 |
| authorships[0].author.display_name | Hui‐Chun Wang |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Hui-Chun Wang |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5027896485 |
| authorships[1].author.orcid | https://orcid.org/0000-0003-0252-0571 |
| authorships[1].author.display_name | Alan Yueh‐Luen Lee |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Alan Yueh-Luen Lee |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5068599611 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-9282-1065 |
| authorships[2].author.display_name | Wen‐Cheng Chou |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Wen-Cheng Chou |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5081033319 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-4203-4084 |
| authorships[3].author.display_name | Chin‐Chung Wu |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Chin-Chung Wu |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5003090307 |
| authorships[4].author.orcid | https://orcid.org/0000-0001-9972-7987 |
| authorships[4].author.display_name | Chao‐Neng Tseng |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Chao-Neng Tseng |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5002391770 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Kevin Yen-Ting Liu |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Kevin Yen-Ting Liu |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5069757702 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | Wen-Lien Lin |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Wen-Lien Lin |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5066399911 |
| authorships[7].author.orcid | https://orcid.org/0000-0003-2549-4193 |
| authorships[7].author.display_name | Fang‐Rong Chang |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Fang-Rong Chang |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A5075724193 |
| authorships[8].author.orcid | |
| authorships[8].author.display_name | Da‐Wei Chuang |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Da-Wei Chuang |
| authorships[8].is_corresponding | False |
| authorships[9].author.id | https://openalex.org/A5023557269 |
| authorships[9].author.orcid | https://orcid.org/0000-0003-0074-3472 |
| authorships[9].author.display_name | Attila Hunyadi |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Attila Hunyadi |
| authorships[9].is_corresponding | False |
| authorships[10].author.id | https://openalex.org/A5100753551 |
| authorships[10].author.orcid | https://orcid.org/0000-0001-7815-2686 |
| authorships[10].author.display_name | Yang‐Chang Wu |
| authorships[10].author_position | last |
| authorships[10].raw_author_name | Yang-Chang Wu |
| authorships[10].is_corresponding | False |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://aacr.figshare.com/articles/journal_contribution/Supplementary_Methods_from_Inhibition_of_ATR-Dependent_Signaling_by_Protoapigenone_and_Its_Derivative_Sensitizes_Cancer_Cells_to_Interstrand_Cross-link_Generating_Agents_i_In_Vitro_i_and_i_In_Vivo_i_/22498293/1/files/39956670.pdf |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Supplementary Methods from Inhibition of ATR-Dependent Signaling by Protoapigenone and Its Derivative Sensitizes Cancer Cells to Interstrand Cross-link–Generating Agents <i>In Vitro</i> and <i>In Vivo</i> |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T12763 |
| primary_topic.field.id | https://openalex.org/fields/13 |
| primary_topic.field.display_name | Biochemistry, Genetics and Molecular Biology |
| primary_topic.score | 0.9925000071525574 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/1312 |
| primary_topic.subfield.display_name | Molecular Biology |
| primary_topic.display_name | ATP Synthase and ATPases Research |
| related_works | https://openalex.org/W2381413256, https://openalex.org/W404290554, https://openalex.org/W14347162, https://openalex.org/W576771434, https://openalex.org/W2408898686, https://openalex.org/W2043468358, https://openalex.org/W2363926780, https://openalex.org/W2348241498, https://openalex.org/W2802815821, https://openalex.org/W379674329 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.1158/1535-7163.22498293 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://aacr.figshare.com/articles/journal_contribution/Supplementary_Methods_from_Inhibition_of_ATR-Dependent_Signaling_by_Protoapigenone_and_Its_Derivative_Sensitizes_Cancer_Cells_to_Interstrand_Cross-link_Generating_Agents_i_In_Vitro_i_and_i_In_Vivo_i_/22498293/1/files/39956670.pdf |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.1158/1535-7163.22498293 |
| primary_location.id | doi:10.1158/1535-7163.22498293 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://aacr.figshare.com/articles/journal_contribution/Supplementary_Methods_from_Inhibition_of_ATR-Dependent_Signaling_by_Protoapigenone_and_Its_Derivative_Sensitizes_Cancer_Cells_to_Interstrand_Cross-link_Generating_Agents_i_In_Vitro_i_and_i_In_Vivo_i_/22498293/1/files/39956670.pdf |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.1158/1535-7163.22498293 |
| publication_date | 2023-04-03 |
| publication_year | 2023 |
| referenced_works_count | 0 |
| abstract_inverted_index.file, | 1 |
| abstract_inverted_index.<p>PDF | 0 |
| abstract_inverted_index.75KB.</p> | 2 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 11 |
| citation_normalized_percentile.value | 0.20131236 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |